Oxford COVID-19 vaccine by SII to be sent for DGCI sanction

According to some sources, the Oxford COVID-19 vaccine made by the Serum Institute of India will be sent for approval to the Drugs Controller General of India (DCGI). A government-appointed panel of experts will send the vaccine for the approval. Made by Oxford University and pharma major AstraZeneca, the Serum Institute of India (SII) is producing the vaccine. On the other hand, Bharat Biotech has teamed up with the Indian Council of Medical Research (ICMR) for its Covaxin. On Wednesday, the two groups had made presentations before the panel. To come up with their data, Pfizer had sought more time. Once the vaccine is cleared for a final time by the DCGI, the centre is looking to start giving vaccine shots from this month.

Tomorrow a dry run for vaccination is planned in all the states. In the national capital, Health Minister Harsh Vardhan will look after and analyse the dry run. The Health Minister stated that the arrangements were like general elections, where even the booth-level groundworks are made. The objective of the dry run is to be prepared for the real rollout. Probable beneficiaries of vaccine will be informed via SMS. He further stated that the frontline workers were the priority. As per Harsh Vardhan, digital certificate will also be given after vaccination.

On the first day of the new year, in the battle against the pandemic, the expert panel endorsing the reasonably priced Oxford vaccine to the drugs regulator is a big progress for India. After the US, the country has the second-biggest number of COVID-19 infections.